Exact Sciences
EXAS
#1645
Rank
C$14.93 B
Marketcap
$80.70
Share price
2.08%
Change (1 day)
-10.00%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -C$0.26 Billion

According to Exact Sciences's latest financial reports the company's current earnings are C$2.69 Billion. In 2023 the company made an earning of -C$0.28 Billion, an increase over its 2022 earnings that were of -C$0.89 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.26 Billion-5.46%
2023 -C$0.28 Billion-69.28%
2022 -C$0.89 Billion-25.55%
2021 -C$1.2 Billion1.68%
2020 -C$1.18 Billion271.17%
2019 -C$0.32 Billion58.99%
2018 -C$0.2 Billion20.89%
2017 -C$0.17 Billion-30.95%
2016 -C$0.24 Billion5.09%
2015 -C$0.23 Billion57.24%
2014 -C$0.15 Billion116.53%
2013 -C$66.68 Million
2011 -C$41.52 Million143.73%
2010 -C$17.04 Million27.85%
2009 -C$13.33 Million0.27%
2008 -C$13.29 Million-20.95%
2007 -C$16.81 Million-13.53%
2006 -C$19.44 Million-10.07%
2005 -C$21.62 Million-21.81%
2004 -C$27.65 Million-33.44%
2003 -C$41.54 Million-6.51%
2002 -C$44.43 Million17.95%
2001 -C$37.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.17 Billion-40.71%๐Ÿ‡บ๐Ÿ‡ธ USA
C$94.88 M-134.38%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$11.77 Million-95.74%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$50.37 Million-81.75%๐Ÿ‡บ๐Ÿ‡ธ USA
C$10.66 B-3,966.20%๐Ÿ‡ซ๐Ÿ‡ท France